Taizhou Xingming Pharmaceutical

Taizhou Xingming Pharmaceutical is a China-based pharmaceutical manufacturing company focused on small-molecule active pharmaceutical ingredients and pharmaceutical intermediates. The company appears to operate primarily as a commercial supplier and manufacturer rather than a clinical-stage drug developer, with reported strengths in adenine, clozapine, sulindac, and related intermediates. Its operations include API production, custom synthesis, contract manufacturing, and research and development services for pharmaceutical customers. Publicly available profiles indicate GMP-oriented manufacturing facilities in Taizhou, Zhejiang, and an export-oriented business serving international markets. The company seems best characterized as an established private pharma manufacturing and supply-chain company rather than an innovation-driven biotech pipeline company.